dengue vaccine development in...
Post on 06-Feb-2018
222 Views
Preview:
TRANSCRIPT
Dengue Vaccine Development in Indonesia
National Vaccine Research Forum Dengue Vaccine Working Group
(UNAIR, UI, UGM, NIH-RD. LIPI, EIJKMAN-IMB, BPPT, PSSP)
http://www.healthmap.org/dengue/en/
Dengue IR & CFR in Indonesia, 1988-2012
11/29/2013 2
Andi Muhaidir, Dengue Vaccine Meeting, Brazil, 9-11 April 2013
Background
• DHF is still a burden and one of health priority in Indonesia
• Vector control has not successfully prevented the outbreak
• No specific treatment for Dengue infection
• Vaccine is one of the potential alternatives in dengue prevention, but none has been established completely
11/29/2013 3
Background (2)
• All 4 types of DV exist in Indonesia
• Indonesian DV’s genotypes are different from those of other countries
• Local strain based Dengue vaccine is required
• All resources should be synergized in harmony to produce vaccine with competitive advantages
11/29/2013 4
Program Development
1.
2.
3.
4.
5.
6.
7. Vaccine development research 11/29/2013 5
Andi Muhaidir, Dengue Vaccine Meeting, Brazil, 9-11 April 2013
Road Map
Mapping 2012-2013
•Serotype & Genotype Geographic Distribution
•Genetic Characterization
•Invitro Biologic Characterization
•Selection and multiplication of Virus Isolates
Seed Virus Candidate
Selection 2013
•Immunogenicity & Antigenicity Analysis
•Candidate Strain determination based on genetic conservation
Vaccine Technology
Development 2013-2015
•Vaccine forms determination
•Adjuvant
•Animal model
Formulation and Assay
Development 2015-2018
•Stability
•Formulation
•Animal testing (mice and primates)
•Antibody Dependent Enhancement testing
Parent Seed Selection
2018-2019
•Vaccine prototypes
Seed Vaccine 2020
•Validation
•Scale up
Eijkman, Litbangkes, UI,
UnAir, UGM
Eijkman, Litbangkes, UI,
UnAir, UGM
UnAir, UI, LIPI, Litbangkes,
BPPT, Biofarma
PSSP IPB, Litbangkes, UI,
UnAir, UGM
Litbangkes, UI, UnAir, UGM,
LIPI, BPPT. Biofarma
11/29/2013 6
Mapping 2012-2013
• Serotype & Genotype Geographic Distribution
– Litbangkes, eijkman, UI, UnAir, UGM
• Genetic Characterization
– Eijkman
• Invitro Biologic Characterization
– Eijkman, UnAir, UI, UGM
• Selection and multiplication of Virus Isolates
– UnAir, UI
11/29/2013 7
IDENTIFIKASI GENOTIPE DAN KARAKTERISASI GENOME VIRUS DENGUE DI INDONESIA UNTUK PENENTUAN PROTOTIPE VIRUS BAHAN PEMBUATAN VAKSIN DENGUE BERBASIS STRAIN INDONESIA
Tedjo Sasmono1), Benediktus Yohan1),Tri Yuli Setianingsih1),Aryati2,3), Puspa Wardhani2,3), Fedik. A. Rantam3)
Dengue srotype distribution in 8 Indonesian cities kota in 2010-2012.
11/29/2013 8
IDENTIFIKASI GENOTIPE DAN KARAKTERISASI GENOME VIRUS DENGUE DI INDONESIA UNTUK PENENTUAN PROTOTIPE VIRUS BAHAN PEMBUATAN VAKSIN DENGUE BERBASIS STRAIN INDONESIA
Tedjo Sasmono1), Benediktus Yohan1),Tri Yuli Setianingsih1),Aryati2,3), Puspa Wardhani2,3), Fedik. A. Rantam3)
11/29/2013 9
Indonesian Dengue Virus genetic characteristic based on its genome sequence
Seed Virus Candidate Selection 2013
• Immunogenicity & Antigenicity Analysis
– UnAir, Eijkman
• Candidate Strain determination based on genetic conservation
– Eijkman, UI
11/29/2013 10
Vaccine Technology Development 2013-2015
• Live attenuated vaccine – UnAir, eijkman
• Inactivated vaccine – UnAir
• Recombinant Live Attenuated (Chimera) – UnAir
• DNA Vaccine – UI
• Subunit vaccine – UI, Litbangkes, BPPT, UnAir
• Adjuvant & Delivery System – LIPI, BF
• Animal model – PSSP IPB
11/29/2013 11
Formulation and Assay Development 2015-2018
• Stability
– UnAir, UI, Litbangkes, Eijkman
• Tetravalent vaccine formulation
– UI, UnAir, Litbangkes
• Animal testing (mice and primates)
– Litbangkes, PSSP IPB, UI, UnAir
• Antibody Dependent Enhancement testing
– UI, Litbangkes, UnAir, UGM
11/29/2013 12
Parent Seed Selection 2018-2019 and Seed Vaccine Development 2020
• Vaccine prototypes – Litbangkes, UnAir, UI, UGM, Eijkman, LIPI, BPPT
• Validation and Scaling up – Biofarma
11/29/2013 13
Shareholder Ministries
• Mo Research & Technology
• Mo Education & Culture
• Mo Health
• Mo Trade & Industry
• Mo Finance
• National Standardization Agency
11/29/2013 14
THANK YOU
11/29/2013 15
top related